Indefinite Delivery Contract 75Q80125D00011

Award Date 7/1/25
Last Date to Order 6/30/30
Federal Agency
AHRQ Headquarters
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Order Dependent (IDV only)
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
This indefinite delivery contract (IDC) with the Agency for Healthcare Research and Quality (AHRQ) is for Evidence-Based Practice Center (EPC) services to provide a variety of evidence synthesis products. The contract holder will respond to task orders from AHRQ and other federal partners to produce reports such as systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across medical specialties. The contract is a multiple award IDIQ with a $90...
The Indefinite Delivery Contract (IDC) ID 75Q80125D00003 was awarded by the Agency for Healthcare Research and Quality (AHRQ) to The Johns Hopkins University, a private non-profit research university, to provide evidence synthesis services for the AHRQ Evidence-based Practice Center (EPC) program. The multiple-award IDC, valued at up to $90 million, has a period of performance from July 2025 through June 2030. Under this IDC, The Johns Hopkins University will respond to task orders to produce...
This Indefinite Delivery Contract (IDC) was awarded by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency, to Brown University, a private Ivy League university, to provide evidence synthesis services for the Evidence-based Practice Center (EPC) program. The IDC has a ceiling value of $90,000 and a period of performance from July 1, 2025 to June 30, 2030. Under this multiple award contract, Brown University will respond to task orders to produce various types of...
The federal contract IDV award is for the Evidence-Based Practice Centers (EPC) VII program, which is managed by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency. The multiple-award IDIQ contract, valued up to $90,000,000, is for a 5-year period of performance from November 2024 to November 2029. The prime contractor is Oregon Health & Science University (OHSU), a state-controlled institution of higher learning. The contracted services include conducting...
The federal contract IDV award is for the Agency for Healthcare Research and Quality's (AHRQ) Evidence-based Practice Center (EPC) program. The $90 million, multiple-award IDIQ contract runs from July 2025 to June 2030, with the prime contractor being the Mayo Clinic. The contract aims to procure a range of evidence synthesis services, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across various medical specialties. These...
This Indefinite Delivery Contract (IDC) was awarded by the Health Resources and Services Administration (HRSA), a civilian agency, to the prime contractor L&M Policy Research, LLC, a minority-owned, woman-owned, and economically disadvantaged small business. The $350 million, single-award IDC has a period of performance from September 2024 to September 2025, with four one-year option periods. The IDC is intended to provide HRSA with a contract mechanism to facilitate the production of...
This Indefinite Delivery Contract (IDC) was awarded by the Health Resources and Services Administration (HRSA), a civilian federal agency, to the prime contractor Customer Value Partners, LLC. The $350 million ceiling value IDC runs through September 2025 and is intended to provide a contract vehicle for HRSA to obtain a range of evidence-building and evaluation services. The contracted services are organized into four key task areas: (1) conducting program evaluations, (2) performing other...
The federal contract IDV award is for the Agency for Healthcare Research and Quality's (AHRQ) Evidence-based Practice Center (EPC) VII program. The $90 million, multiple-award IDIQ contract has a period of performance from July 2025 to June 2030. The prime contractor, Emergency Care Research Institute (Ecri), is a non-profit organization that provides healthcare quality and safety services to federal agencies. Under this IDV, Ecri will deliver a variety of evidence synthesis products,...
The federal contract IDV award is for the Evidence-based Practice Center (EPC) VII program, which is administered by the Agency for Healthcare Research and Quality (AHRQ), a civilian federal agency. The prime contractor is The RAND Corporation, a non-profit global policy think tank. The contract aims to procure evidence synthesis services, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis across a wide range of medical specialties....
This is a multiple award Indefinite Delivery Contract (IDC) awarded by the Agency for Healthcare Research and Quality (AHRQ) to the University of Kansas Medical Center Research Institute, Inc. (KUMCRI) for the Evidence-based Practice Center (EPC) VII program. The contract has a ceiling value of $90,000.00 and a period of performance from July 1, 2025 to June 30, 2030. The EPC VII program requires the prime contractor to provide a variety of evidence synthesis services, including systematic...

This indefinite delivery contract (IDC) was awarded by the Agency for Healthcare Research and Quality (AHRQ) to the University of Southern California (USC) to provide evidence synthesis services for the AHRQ Evidence-based Practice Center (EPC) program. The multiple-award IDC has a $90 million ceiling value and a period of performance from July 1, 2025 to June 30, 2030.

Under this contract, USC will produce various types of evidence reports, including systematic reviews, scoping reviews, living reviews, rapid reviews, and qualitative evidence synthesis, across a wide range of medical specialties. The reports will support federal agencies, guideline developers, clinicians, patients, policymakers, research funders, and other stakeholders in translating evidence into practice and policy to improve patient care and outcomes. The contract enables USC to provide comprehensive genomic analysis capabilities to the scientific community through a related Genome Characterization Center services IDC valued at approximately $150 million.

Generated 7/1/25, 9:54 AM